Stevanato Group S.p.A.NYSE: STVN

Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026

· Issued by Stevanato Group S.p.A. via Business Wire

Summary by 6ix AI

Stevanato Group S.p.A., a provider of drug containment, drug delivery and diagnostic products to the pharmaceutical, biotechnology and life sciences industries, will issue its second quarter 2026 financial results on Tuesday, August 4, 2026, at 6:30 a.m. (EDT).

Key details

  • A conference call and webcast to discuss the results will be held at 8:30 a.m. (EDT) on Tuesday, August 4, 2026.
  • Management will refer to a slide presentation that will be available on the morning of the call on the Financial Results page of the Investor Relations section of the company's website.
  • A live, listen-only webcast will be available, and the webcast will be archived for three months on the Investor Relations section of the company's website.

6ix AI wrote this summary from the release below and checked it against the release.

PIOMBINO DESE, Italy, July 21, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the second quarter of 2026 on Tuesday, August 4, 2026, at 6:30 a.m. (EDT).

Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (EDT) on Tuesday, August 4, 2026, to discuss financial results. During the call, management will refer to a slide presentation which will be available on the morning of the call on the "Financial Results" page under the Company's Investor Relations section of its website.

Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. We encourage participants to pre-register for the conference call using the following link: STVN conference call pre-registration.

Webcast: A live, listen-only webcast of the call will be available at the following link: STVN webcast.

Dial in: Those who are unable to pre-register may dial in by calling:

Italy:

+39 02 802 09 11

United Kingdom:

+44 1 212 818004

United States:

+1 718 705 8796

United States Toll Free:

+1 855 265 6958

Questions during the call: Participants who wish to ask questions during the call should use the HD webphone link: https://hditalia.choruscall.com/?$Y2FsbHR5cGU9MiZpbmZvPWNvbXBhbnk=

Replay: The webcast will be archived for three months on the Company's Investor Relations section of its website.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages. Stevanato Group's core capabilities in scientific research and development, its commitment to technical innovation, and its engineering excellence are central to its ability to offer value-added solutions to clients. To learn more, visit: www.stevanatogroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260721394233/en/

Contacts

Investor Relations
Lisa Miles: [email protected]
Giacomo Guiducci: [email protected]
Media
Caterina Tripepi: [email protected]
Stefania Bassi: [email protected] (Italy)
Marco Lastrico: [email protected] (U.S.)

View original source (Business Wire)Stevanato Group S.p.A. on 6ix

Story so far

Earlier from Stevanato

Later from Stevanato

All Stevanato news releases